BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 16306922)

  • 1. Ambulatory monitoring of aborted sudden cardiac death related to hypertrophic cardiomyopathy.
    Vaglio JC; Sorajja P; Gersh BJ
    Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):659-62; quiz following 662. PubMed ID: 16306922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden death as a presenting symptom of hypertrophic cardiomyopathy: treatment with an implantable cardioverter defibrillator.
    Talard P; Lévy S; Bonal J; Paganelli F; Bouchiat C; Cellarier G; Dussarat GV
    Pacing Clin Electrophysiol; 1996 Aug; 19(8):1264-7. PubMed ID: 8865227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-modality imaging in an exceptional case of aborted sudden cardiac death.
    Sonck J; Tanaka K; Czapla J; Vanderhasselt T; Kayaert P; Scott B; Sutherland G; Van Camp G
    Int J Cardiol; 2014 Feb; 171(2):e57-8. PubMed ID: 24365616
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Obergassel L; Lieder F; Leuner C; Strunk-Mueller C; Meyer Zu Vilsendorf D; Beer G; Kuhn H
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):295-300. PubMed ID: 15826262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy.
    Balt JC; Wijffels MC; Boersma LV; Wever EF; ten Berg JM
    Heart; 2014 Dec; 100(23):1865-70. PubMed ID: 25073885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of hypertrophic cardiomyopathies].
    Kühl C; Luedde M; Langer C; Frey N
    Dtsch Med Wochenschr; 2013 Mar; 138(12):583-8. PubMed ID: 23483418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol septal ablation versus surgical myectomy: a patient with obstructive HCM.
    La Canna G; Airoldi F; Capritti E; Grimaldi A; Colombo A; Alfieri O
    Nat Clin Pract Cardiovasc Med; 2007 Oct; 4(10):570-6. PubMed ID: 17893685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy.
    Wang S; Cui H; Ji K; Song C; Ren C; Guo H; Zhu C; Wang S; Lai Y
    Cardiovasc Diabetol; 2020 May; 19(1):64. PubMed ID: 32404127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
    McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
    Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subaortic and midventricular obstructive hypertrophic cardiomyopathy with extreme segmental hypertrophy.
    Efthimiadis GK; Giannakoulas G; Parcharidou DG; Ziakas AG; Papadopoulos CE; Karoulas T; Pliakos C; Parcharidis G
    Cardiovasc Ultrasound; 2007 Mar; 5():12. PubMed ID: 17349063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 15. Ambulatory monitoring of the sudden death of an adolescent with hypertrophic cardiomyopathy.
    Gardin LL; Nanton MA; Hanna BD
    Can J Cardiol; 1994 Jun; 10(5):548-50. PubMed ID: 8012885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm and sustained ventricular tachycardia: a case report].
    Kono K; Higashi T; Hara K; Mori S; Ito I; Shinbo G; Anzai R; Yagi H; Tamano K; Horinaka S; Matsuoka H
    J Cardiol; 2001 Dec; 38(6):343-9. PubMed ID: 11806092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
    Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
    JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can septal myectomy prevent sudden cardiac death in hypertrophic obstructive cardiomyopathy?
    Efthimiadis GK; Meditskou S; Mezilis NE; Styliadis I; Manthos A; Parcharidis GE
    Eur Heart J; 2007 Sep; 28(17):2177; author reply 2177-8. PubMed ID: 17670761
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sudden death during Holter electrocardiographic monitoring in a patient with hypertrophic cardiomyopathy].
    Sato M; Takenaka K; Yamashita T; Koike S; Natori K; Nakahara K
    J Cardiol; 1998 May; 31(5):297-303. PubMed ID: 9617660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary myocardial contrast echocardiography in a patient with drug refractory hypertrophic obstructive cardiomyopathy revealing extensive myocardium at risk for infarction with alcohol septal ablation.
    Monakier D; Horlick E; Ross J; Woo A; Rakowski H; Schwartz L; Riley MP; Carver JR; Aggarwal K; James EA; Aziz S; Ramsdale DR
    J Invasive Cardiol; 2004 Sep; 16(9):482-4. PubMed ID: 15353829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.